HEALTH professionals are advised that the Therapeutic Goods Administration (TGA) has suspended the licence to supply Philips IntelliVue MX40 wearable patient monitor after identifying a significant increase in reports of incidents where the device's speaker has failed.
Go to tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 May 17
